| 763958 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
836 Murine fecal microbiota transfer models colonize human microbes selectively and reveal transcriptional pathways associated with response to neoadjuvant checkpoint inhibitors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.836 |
Shaikh Fyza, Gills Joell, Mohammad Fuad, White James, Stevens Courtney, Ding Hua, Fu Juan, Tam Ada, Blosser Richard, Larman Tatianna, Naidoo Jarushka, Forde Patrick, Ganguly Sudipto, Housseau Franck, Pardoll Drew, Sears Cynthia |
| 763957 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
835 Harnessing the microbiota to increase response rates to immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.835 |
Ferrari Valentina, Melacarne Alessia, Algieri Francesca, Rescigno Maria |
| 763956 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
743 Resistance to oncolytic vaccinia can be reversed by targeting regulatory T cells with vaccinia-directed delivery of a TGFβ inhibitor |
2021-11-01 |
10.1136/jitc-2021-sitc2021.743 |
DePeaux Kristin, Rivadeneira Dayana, Watson McLane, Hinck Andrew, Thorne Stephen, Delgoffe Greg |
| 763955 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
742 Multi-armed myxoma virus induces potent anti-tumor responses in vitro and in vivo |
2021-11-01 |
10.1136/jitc-2021-sitc2021.742 |
Abdullahi Wazir, Franco Lina, Fraser Christopher, Hrach Heather, Grigaitis Nicole, Abrantes Mario, Tacner Zachary, Matos Ana de, Sharp Leslie |
| 763954 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
741 Expression of galectin-3 inhibitors from a self-replicating RNA vector as treatment for pediatric osteasarcoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.741 |
Cañete Guillermo Herrador, Zalacain Marta, Labiano Sara, Martinez Javier, Smerdou Cristian, Alonso Marta |
| 763953 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
740 Radiotherapy-activated NBTXR3 nanoparticles Increase CD8+ T cell infiltration and diversity in tumors, and modulate the immunopeptidome of cancer cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.740 |
Darmon Audrey, Zhang Ping, silva Jordan Da, Paris Sebastien |
| 763952 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
739 Intratumor childhood vaccine-specific CD4+ T cell recall helps antitumor CD8 T cells |
2021-11-01 |
10.1136/jitc-2021-sitc2021.739 |
Brown Michael, McKay Zachary, Yang Yuanfan, Bigner Darell, Nair Smita, Gromeier Matthias |
| 763951 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
494 Phase 1 dose escalation and dose expansion study of an agonist redirected checkpoint (ARC) fusion protein, SL-279252 (PD1-Fc-OX40L), in subjects with advanced solid tumors or lymphomas |
2021-11-01 |
10.1136/jitc-2021-sitc2021.494 |
Johnson Melissa, Siu Lilian, Hong David, Schoffski Patrick, Galvao Vladimir, Rangwala Fatima, Hernandez Robert, Gonzalez Louis, Ma Bo, Pandite Lini, Brana Irene |
| 763950 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
492 Phase 2 efficacy and safety of autologous tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab in immune checkpoint inhibitor-naïve patients with advanced cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.492 |
O’Malley David, Lee Sylvia, Psyrri Amanda, Sukari Ammar, Thomas Sajeve, Wenham Robert, Gogas Helen, Jazaeri Amir, Monk Bradley, Rose Peter, Reuda Antonio, Finckenstein Friedrich Graf, Jagasia Madan, Fiaz Rana, Garelik Brigid, Shi Wen, Desai Anjali, Sulur Giri, Chen Guang, Wu Xiao, Jimeno Antonio |
| 763949 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
490 Clinical benefit through Siglec-15 targeting with NC318 antibody in subjects with Siglec-15 positive advanced solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.490 |
Shum Elaine, Myint Han, Shaik Jahangheer, Zhou Qinjie, Barbu Emilia, Morawski Aaron, Abukharma Hasan, Liu Linda, Nelson Megan, Zeidan Stephanie, Cusumano Zachary, Tolcher Anthony, Langermann Solomon, Gutierrez Martin, Hamid Omid |
